These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 12442922)
1. Safety and efficacy of concurrent cisplatin and radiotherapy in inoperable or metastatic squamous cell esophageal cancer. Kumar S; Dimri K; Datta NR; Rastogi N; Lal P; Das KJ; Ayyagari S Acta Oncol; 2002; 41(5):457-62. PubMed ID: 12442922 [TBL] [Abstract][Full Text] [Related]
2. [Role of an exclusive concomitant radio-chemotherapy treatment in non operable esophageal cancer: results of a 10-year experience in Antoine-Lacassagne Center]. Magné N; François E; Touati L; Marcy PY; Van Houtte P; Lagrange JL Bull Cancer; 2005 Feb; 92(2):184-90. PubMed ID: 15749648 [TBL] [Abstract][Full Text] [Related]
3. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Kumar S; Dimri K; Khurana R; Rastogi N; Das KJ; Lal P Radiother Oncol; 2007 May; 83(2):139-47. PubMed ID: 17445928 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia. Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654 [TBL] [Abstract][Full Text] [Related]
5. Conventional radiotherapy with concurrent weekly Cisplatin in locally advanced head and neck cancers of squamous cell origin - a single institution experience. Dimri K; Pandey AK; Trehan R; Rai B; Kumar A Asian Pac J Cancer Prev; 2013; 14(11):6883-8. PubMed ID: 24377620 [TBL] [Abstract][Full Text] [Related]
6. Factors influencing the development of ulcers and strictures in carcinoma of the esophagus treated with radiotherapy with or without concurrent chemotherapy. Khurana R; Dimri K; Lal P; Rastogi N; Joseph K; Das M; Kumar S J Cancer Res Ther; 2007; 3(1):2-7. PubMed ID: 17998711 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus. Stuschke M; Stahl M; Wilke H; Walz M; Oldenburg A; Stüben G; Seeber S; Sack H Am J Clin Oncol; 2000 Jun; 23(3):233-8. PubMed ID: 10857883 [TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study. Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993 [TBL] [Abstract][Full Text] [Related]
9. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Kleinberg L; Knisely JP; Heitmiller R; Zahurak M; Salem R; Burtness B; Heath EI; Forastiere AA Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):328-34. PubMed ID: 12738305 [TBL] [Abstract][Full Text] [Related]
10. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma. Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of post-operative radiotherapy with concurrent chemotherapy for high-risk squamous cell carcinoma of the cervical esophagus. Daiko H; Hayashi R; Sakuraba M; Ebihara M; Miyazaki M; Shinozaki T; Saikawa M; Zenda S; Kawashima M; Tahara M; Doi T; Ohtsu A Jpn J Clin Oncol; 2011 Apr; 41(4):508-13. PubMed ID: 21335338 [TBL] [Abstract][Full Text] [Related]
12. Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer. Watkins JM; Zauls AJ; Kearney PL; Shirai K; Ruppert BN; Harper JL; Sherman CA; Aguero EG; Reed CE; Sharma AK Jpn J Clin Oncol; 2011 Mar; 41(3):334-42. PubMed ID: 21084436 [TBL] [Abstract][Full Text] [Related]
13. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma. Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175 [TBL] [Abstract][Full Text] [Related]
14. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01). Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R; Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399 [TBL] [Abstract][Full Text] [Related]
15. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546 [TBL] [Abstract][Full Text] [Related]
16. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207). Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897 [TBL] [Abstract][Full Text] [Related]
17. [Radiotherapy of esophageal cancer. Results following radiotherapy alone and simultaneous radiochemotherapy and intracavitary irradiation]. Fietkau R; Grabenbauer GG; Sauer R Strahlenther Onkol; 1994 Feb; 170(2):69-78. PubMed ID: 8108784 [TBL] [Abstract][Full Text] [Related]
18. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]. Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ; Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962 [TBL] [Abstract][Full Text] [Related]
19. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma]. Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288 [TBL] [Abstract][Full Text] [Related]
20. Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604). Tahara M; Fuse N; Mizusawa J; Sato A; Nihei K; Kanato K; Kato K; Yamazaki K; Muro K; Takaishi H; Boku N; Ohtsu A Cancer Sci; 2015 Oct; 106(10):1414-20. PubMed ID: 26250827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]